Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
December 2015 onwards
Submit An Event
October 2014 Onwards
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
01 Oct 2014 - 01 Oct 2014
Webinar: How to improve your antibody drug development assays with anti-idiotypic antibodies
06 Oct 2014 - 08 Oct 2014
Grand Hyatt New York, New York, United States of America
22nd Annual International Cancer Immunotherapy Symposium
08 Oct 2014 - 09 Oct 2014
08 Oct 2014 - 08 Oct 2014
Webinar - Targeting Solid and Liquid Tumors With Bi-Specific Antibody Armed T cells.
09 Oct 2014 - 11 Oct 2014
Houston, TX, USA
MSTS Annual Meeting
13 Oct 2014 - 15 Oct 2014
World Vaccine Congress Europe 2014
15 Oct 2014 - 16 Oct 2014
Advances in Cancer Immunotherapies 2014 (ACI2014)
19 Oct 2014 - 20 Oct 2014
4th China BioPharma Convention-Antibody & Vaccine Focus 2014
20 Oct 2014 - 22 Oct 2014
Boston, MA, USA
15th Annual Immunogenicity for Biotherapeutics
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,400+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!